A major breakthrough for diabetes care has arrived in India. Novo Nordisk has launched Awiqli, the world's first once-weekly insulin, reducing the need for 365 injections a year to just 52. The innovation could transform diabetes management for millions of Indians by making insulin therapy simpler and more convenient.